Geneos Wealth Management’s Flowserve FLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-35
Closed -$1.6K – 2104
2024
Q1
$1.6K Buy
+35
New +$1.47K ﹤0.01% 1931
2018
Q4
– Sell
-800
Closed -$43K – 2417
2018
Q3
$43K Hold
800
– – ﹤0.01% 1243
2018
Q2
$32K Hold
800
– – ﹤0.01% 1250
2018
Q1
$34K Sell
800
-238
-23% -$10.4K ﹤0.01% 1168
2017
Q4
$43K Sell
1,038
-1,006
-49% -$42.1K ﹤0.01% 1068
2017
Q3
$87K Sell
2,044
-82
-4% -$3.45K 0.01% 741
2017
Q2
$98K Sell
2,126
-72
-3% -$3.47K 0.01% 685
2017
Q1
$106K Hold
2,198
– – 0.01% 643
2016
Q4
$105K Sell
2,198
-22
-1% -$1.02K 0.01% 605
2016
Q3
$107K Sell
2,220
-59
-3% -$2.8K 0.01% 583
2016
Q2
$103K Sell
2,279
-21
-0.9% -$983 0.01% 579
2016
Q1
$100K Buy
+2,300
New +$94.9K 0.02% 579

Other funds holding FLS

Geneos Wealth Management's FLS Position: Q2 2024 in Review

Geneos Wealth Management sold out of Flowserve (FLS) in Q2 2024, closing a stake of 35 shares — an estimated $1.6K sold.

Geneos Wealth Management first reported a position in FLS in Q1 2016 and held it in 12 quarters. The position peaked at $107K in Q3 2016. 418 funds tracked by Wall St. Rank hold FLS as of Q2 2024.

  • Geneos Wealth Management reported no remaining Flowserve position as of Q2 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 35 Flowserve shares in Q2 2024, an estimated $1.6K.
  • Geneos Wealth Management first reported a position in Flowserve in Q1 2016 and held it in 12 quarters.
  • Geneos Wealth Management's Flowserve position peaked at $107K in Q3 2016.
  • 418 funds tracked by Wall St. Rank held Flowserve as of Q2 2024.

Based on Geneos Wealth Management's 13F filing for Q2 2024, filed 23 Jul 2024.